1 / 3
google
Article details
- Package size
- 1 x 21
- Selling units
- 21
- Measure
- Tablette(n)
- Galenic form
- Tabletten
- Galenic group
- Tabletten
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
0.075 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
0.03 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
59.12 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Authorization holder
Spirig HealthCare AG
4622 Egerkingen
Authorization information
- Swissmedic authorization number
- 69017
- Drug name
- Gyselle 30, Tabletten
- Galenic form
- TAB
- ATC Code
- G03AA10
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 27/11/2023
- Authorization expiration date
- 26/11/2028
- IT Number
- 09.02.1.
- Domain
- Human medicine
Package details
- Description (FR)
- GYSELLE 30 cpr 21 pce
- Description (DE)
- GYSELLE 30 Tabl 21 Stk
- Market launch
- 27/11/2023
- Narcotic (BTM)
- No